Clinical trial
An Observational, Multi-Center, Multi-National, Long Term Follow-Up Study of Atypical Hemolytic Uremic Syndrome (aHUS) Patients Treated With Eculizumab in a Prior Clinical Study
NCT01522170 is registered in ClinicalTrials.gov with Alexion Pharmaceuticals, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational, Multi-Center, Multi-National, Long Term Follow-Up Study of Atypical Hemolytic Uremic Syndrome (aHUS) Patients Treated With Eculizumab in a Prior Clinical Study
- Lead sponsor
- Alexion Pharmaceuticals, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- March 31, 2012
- Completion date
- January 31, 2017
- Enrollment
- 94 (actual)
- Sites
- 56
Conditions
As the registry lists them; a condition with its own page is linked.